Ray Therapeutics snags $6m seed

Ray Therapeutics, a developer of optogenetic gene therapies for patients with blinding diseases, has raised $6 million in seed financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this